Active site-directed thrombin inhibitors--II. Studies related to arginine/guanidine bioisosteres. 1995

D R St Laurent, and N Balasubramanian, and W T Han, and A Trehan, and M E Federici, and N A Meanwell, and J J Wright, and S M Seiler
Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492-7660, USA.

A series of N-arylsulfonylarginine amides was synthesized wherein the guanidine or arginine moiety was isosterically replaced by a number of heterocyclic functionalities. These compounds were evaluated as potential active-site inhibitors of thrombin. Bisamidines 11a-n showed a similar SAR to that of simple arginine compounds. The ex vivo clotting time measurement of 11d after ip dosing showed prolongation of clotting time in rats.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000991 Antithrombins Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. Antithrombin,Direct Antithrombin,Direct Antithrombins,Direct Thrombin Inhibitor,Direct Thrombin Inhibitors,Antithrombin, Direct,Antithrombins, Direct,Inhibitor, Direct Thrombin,Thrombin Inhibitor, Direct,Thrombin Inhibitors, Direct
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

D R St Laurent, and N Balasubramanian, and W T Han, and A Trehan, and M E Federici, and N A Meanwell, and J J Wright, and S M Seiler
August 1995, Bioorganic & medicinal chemistry,
D R St Laurent, and N Balasubramanian, and W T Han, and A Trehan, and M E Federici, and N A Meanwell, and J J Wright, and S M Seiler
October 1991, The Journal of biological chemistry,
D R St Laurent, and N Balasubramanian, and W T Han, and A Trehan, and M E Federici, and N A Meanwell, and J J Wright, and S M Seiler
April 1999, Journal of protein chemistry,
D R St Laurent, and N Balasubramanian, and W T Han, and A Trehan, and M E Federici, and N A Meanwell, and J J Wright, and S M Seiler
August 1995, Bioorganic & medicinal chemistry,
D R St Laurent, and N Balasubramanian, and W T Han, and A Trehan, and M E Federici, and N A Meanwell, and J J Wright, and S M Seiler
January 2000, Bioorganic & medicinal chemistry letters,
D R St Laurent, and N Balasubramanian, and W T Han, and A Trehan, and M E Federici, and N A Meanwell, and J J Wright, and S M Seiler
March 1994, Journal of biochemistry,
D R St Laurent, and N Balasubramanian, and W T Han, and A Trehan, and M E Federici, and N A Meanwell, and J J Wright, and S M Seiler
November 1971, Annals of the New York Academy of Sciences,
D R St Laurent, and N Balasubramanian, and W T Han, and A Trehan, and M E Federici, and N A Meanwell, and J J Wright, and S M Seiler
June 1975, Annals of the New York Academy of Sciences,
D R St Laurent, and N Balasubramanian, and W T Han, and A Trehan, and M E Federici, and N A Meanwell, and J J Wright, and S M Seiler
August 1995, Bioorganic & medicinal chemistry,
D R St Laurent, and N Balasubramanian, and W T Han, and A Trehan, and M E Federici, and N A Meanwell, and J J Wright, and S M Seiler
January 1996, Seminars in thrombosis and hemostasis,
Copied contents to your clipboard!